TWD 19.5
(-1.02%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 39.38 Million | -36.62 Million | -171.06 Million | -2.96 Million | - |
Net Income | 7.94 Million | -24.28 Million | -154.03 Million | -137.75 Million | - |
Depreciation & Amortization | 114.67 Million | 118.65 Million | 127.29 Million | 115.37 Million | - |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | -49.66 Million | -132.62 Million | -141.27 Million | -33.7 Million | - |
Other non-cash items | 56.56 Million | 63.78 Million | 48.79 Million | 70.08 Million | - |
Investing Cash Flow | -171.75 Million | -93.56 Million | -141.26 Million | -158.56 Million | - |
Investments in PPE | -36.37 Million | -75.55 Million | -99.62 Million | -176.32 Million | - |
Acquisitions | 22.13 Million | - | - | - | 611 Thousand |
Investment purchases | -157.48 Million | -24.82 Million | -50.98 Million | -3.39 Million | - |
Sales/Maturities of investments | - | - | - | - | - |
Other Investing Activities | -35 Thousand | 6.32 Million | -8.56 Million | 200 Thousand | - |
Financing Cash Flow | 84.15 Million | 134.7 Million | 252.59 Million | 216.58 Million | - |
Debt repayment | -87.39 Million | -137.06 Million | -23.16 Million | -228.7 Million | - |
Dividends payments | - | - | - | -9.82 Million | -13.92 Million |
Common Stock Repurchased | - | - | - | - | -34.65 Million |
Common Stock Issuance | - | - | 249.98 Million | - | -13.92 Million |
Other Financing Activities | -531 Thousand | -355 Thousand | -16.84 Million | 4.5 Million | - |
Accounts receivables | -77.35 Million | - | - | - | - |
Accounts payables | 7.1 Million | - | - | - | - |
Inventory | -7.25 Million | -70.99 Million | -137.08 Million | -11.64 Million | - |
Other working capital | 34.94 Million | - | - | - | - |
Cash at beginning of period | 262.69 Million | 258.55 Million | 319.12 Million | 264.77 Million | - |
Cash at end of period | 214.61 Million | 262.69 Million | 258.55 Million | 319.12 Million | - |
Capital Expenditure | -36.37 Million | -75.55 Million | -99.62 Million | -176.32 Million | - |
Effect of forex changes on cash | 131 Thousand | -383 Thousand | -840 Thousand | -693 Thousand | - |
Net cash flow / Change in cash | -48.07 Million | 4.13 Million | -60.57 Million | 54.35 Million | - |
Free Cash Flow | 3.01 Million | -112.18 Million | -270.68 Million | -179.28 Million | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 2.32 Million | 4.86 Million | 7.94 Million | 1.41 Million | 30.5 Million | 456 Thousand |
Depreciation & Amortization | 25.52 Million | 27.74 Million | 114.67 Million | 28.25 Million | 28.76 Million | 28.56 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -4.09 Million | 73.71 Million | -49.66 Million | 60.55 Million | -93.23 Million | -17.47 Million |
Other non-cash items | 17.2 Million | 19.39 Million | 56.56 Million | 18.82 Million | 19.68 Million | 18 Thousand |
Investing Cash Flow | -237 Thousand | -14.86 Million | -171.75 Million | -31.35 Million | -55.34 Million | -38.84 Million |
Investments in PPE | -2.45 Million | -15.1 Million | -36.37 Million | -3.92 Million | -16.2 Million | -2.65 Million |
Acquisitions | -505 Thousand | - | - | - | - | - |
Investment purchases | 4.07 Million | -221 Thousand | -157.48 Million | -27.69 Million | -59.52 Million | -37.93 Million |
Sales/Maturities of investments | 3.85 Million | - | - | - | - | - |
Other Investing Activities | -1.35 Million | -43 Thousand | -35 Thousand | 254 Thousand | 90 Thousand | -17 Thousand |
Financing Cash Flow | -19.32 Million | 56.49 Million | 84.15 Million | 10.18 Million | 21.85 Million | 43.58 Million |
Debt repayment | -18.67 Million | -57.21 Million | -87.39 Million | -11.16 Million | -22.6 Million | -44.29 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 29.4 Million | - | -531 Thousand | -343 Thousand | -100 Thousand | 1000.00 |
Accounts receivables | -24.77 Million | - | - | - | - | - |
Accounts payables | 4.66 Million | - | - | - | - | - |
Inventory | 36.64 Million | 14.83 Million | -7.25 Million | 57.5 Million | -17.88 Million | 4.69 Million |
Other working capital | -16.95 Million | - | - | - | - | - |
Cash at beginning of period | 368.29 Million | 214.61 Million | 262.69 Million | 154.26 Million | 232.85 Million | 232.76 Million |
Cash at end of period | 376.05 Million | 368.29 Million | 214.61 Million | 214.61 Million | 154.26 Million | 232.85 Million |
Capital Expenditure | -2.45 Million | -15.1 Million | -36.37 Million | -3.92 Million | -16.2 Million | -2.65 Million |
Effect of forex changes on cash | 2.15 Million | 5.25 Million | 131 Thousand | -8.94 Million | 4.29 Million | 2.03 Million |
Net cash flow / Change in cash | 7.76 Million | 153.67 Million | -48.07 Million | 60.35 Million | -78.58 Million | 81 Thousand |
Free Cash Flow | 22.72 Million | 91.69 Million | 3.01 Million | 86.55 Million | -65.6 Million | -9.34 Million |
BRTHF
MUA
AARTIDRUGS
2122
ZJYL
FSL